I feel bemused by all the recent developments.  The kidney conference was all important; Don McCaffrey has said that the kidney data is the most compelling piece they have.  And now we don't even have a late breaking slot...just a poster?  I find it profoundly disturbing.

The Covid 19 talk is all well and good, but we have a molecule, not an approved drug.  It will be some stretch to get this to be a drug, even if the research shows it works for Covid19.  

Meanwhile, we have a company badly in need of cash...facing a world that is melting down and where capital is suddenly very expensive. Eli Lilly just put a halt on all their research projects.  I am sure Pfizer etc (potential buyers of RVX) are doing the same slashing of expenses. 

None of these companies are going to be willing to buy RVX now...even at a knock down price.  Can you imagine Eli Lilly board asking the obvious question: capital is tight, and you want to spend it on a deal with this unknown company from Calgary?

And the company is suddenly quiet...or releasing information which is not clear in its agenda.

I am uneasy about where this company is heading.